Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Evolving Chemotherapy Options for the Treatment of Myeloma Kidney: A 40-Year Perspective — Efstathios Kastritis (2012) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Evolving Chemotherapy Options for the Treatment of Myeloma Kidney: A 40-Year Perspective
Shared by
Meletios A Dimopoulos
Evolving Chemotherapy Options for the Treatment of Myeloma Kidney: A 40-Year Perspective
Article
2012
en
Authors
EK
Efstathios Kastritis
Meletios A Dimopoulos
JB
Joan Bladé
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2005
Current treatment options for myeloma
Evangelos Terpos
,
Amin Rahemtulla
,
Meletios A Dimopoulos
Article
1994
Options for Primary Chemotherapy in Advanced Ovarian Cancer: The European Perspective
Nicoletta Colombo
,
Aldo Maggioni
,
M. Vignali
,
Gabriel Parma
,
Costantino Mangioni
Article
2011
A 40-Year Journey in Search of Selective Antiviral Chemotherapy*
De Clercq Erik
Article
2015
Treatment options for relapsed and refractory multiple myeloma
Ajay K. Nooka
,
Efstathios Kastritis
,
Meletios A Dimopoulos
,
Sagar Lonial
Article
2022
Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple Myeloma
Meletios A Dimopoulos
,
Paul G. Richardson
,
Sagar Lonial
Discussion(0)
No comments yet. Be the first to comment.